Full-Time
Updated on 11/19/2024
Non-invasive cardiac testing technology provider
$135kAnnually
Senior
Long Island, New York, USA
Expect approximately 20-25% travel from a home office.
HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning. The goal is to improve cardiovascular care by making it safer and more efficient.
Company Stage
Series F
Total Funding
$858.5M
Headquarters
Redwood City, California
Founded
2010
Help us improve and share your feedback! Did you find this helpful?